These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 29124112)

  • 41. 2021 Alzheimer's disease facts and figures.
    Alzheimers Dement; 2021 Mar; 17(3):327-406. PubMed ID: 33756057
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tailoring and evaluating an intervention to improve shared decision-making among seniors with dementia, their caregivers, and healthcare providers: study protocol for a randomized controlled trial.
    Giguere AMC; Lawani MA; Fortier-Brochu É; Carmichael PH; Légaré F; Kröger E; Witteman HO; Voyer P; Caron D; Rodríguez C
    Trials; 2018 Jun; 19(1):332. PubMed ID: 29941020
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Legal & ethical compliance when sharing biospecimen.
    Klingstrom T; Bongcam-Rudloff E; Reichel J
    Brief Funct Genomics; 2018 Jan; 17(1):1-7. PubMed ID: 28460118
    [TBL] [Abstract][Full Text] [Related]  

  • 44. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
    Jack CR; Bennett DA; Blennow K; Carrillo MC; Dunn B; Haeberlein SB; Holtzman DM; Jagust W; Jessen F; Karlawish J; Liu E; Molinuevo JL; Montine T; Phelps C; Rankin KP; Rowe CC; Scheltens P; Siemers E; Snyder HM; Sperling R;
    Alzheimers Dement; 2018 Apr; 14(4):535-562. PubMed ID: 29653606
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The 'interesting case' and patient privacy: handling patient data in medical education].
    Leijssen LG; Linthorst GE; Geukers V; Ploem MC
    Ned Tijdschr Geneeskd; 2015; 159():A9458. PubMed ID: 26469735
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Editorial: Impacts of public-private collaborative research on Alzheimer's disease: the case of the innovative medicines initiative.
    Vaudano E; Georges J; Hofmann-Apitius M; Lo D
    Front Neurol; 2023; 14():1321225. PubMed ID: 38093752
    [No Abstract]   [Full Text] [Related]  

  • 47. Preparing accessible and understandable clinical research participant information leaflets and consent forms: a set of guidelines from an expert consensus conference.
    Coleman E; O'Sullivan L; Crowley R; Hanbidge M; Driver S; Kroll T; Kelly A; Nichol A; McCarthy O; Sukumar P; Doran P
    Res Involv Engagem; 2021 May; 7(1):31. PubMed ID: 34006326
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Patients come from populations and populations contain patients. A two-stage scientific and ethics review: The next adaptation for single institutional review boards.
    Knopman D; Alford E; Tate K; Long M; Khachaturian AS
    Alzheimers Dement; 2017 Aug; 13(8):940-946. PubMed ID: 28709585
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Taking stock: A multistakeholder perspective on improving the delivery of care and the development of treatments for Alzheimer's disease.
    Bradley P; Akehurst R; Ballard C; Banerjee S; Blennow K; Bremner J; Broich K; Cummings J; Dening K; Dubois B; Klipper W; Leibman C; Mantua V; Molinuevo JL; Morgan S; Muscolo LA; Nicolas F; Pani L; Robinson L; Siviero P; van Dam J; Van Emelen J; Wimo A; Wortmann M; Goh L
    Alzheimers Dement; 2015 Apr; 11(4):455-61. PubMed ID: 24751826
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Challenges arising when seeking broad consent for health research data sharing: a qualitative study of perspectives in Thailand.
    Cheah PY; Jatupornpimol N; Hanboonkunupakarn B; Khirikoekkong N; Jittamala P; Pukrittayakamee S; Day NPJ; Parker M; Bull S
    BMC Med Ethics; 2018 Nov; 19(1):86. PubMed ID: 30404642
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative Study.
    Mohs RC; Knopman D; Petersen RC; Ferris SH; Ernesto C; Grundman M; Sano M; Bieliauskas L; Geldmacher D; Clark C; Thal LJ
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 2():S13-21. PubMed ID: 9236948
    [TBL] [Abstract][Full Text] [Related]  

  • 52. How legislation on decisional capacity can negatively affect the feasibility of clinical trials in patients with dementia.
    Galeotti F; Vanacore N; Gainotti S; Izzicupo F; Menniti-Ippolito F; Petrini C; Chiarotti F; Chattat R; Raschetti R;
    Drugs Aging; 2012 Aug; 29(8):607-14. PubMed ID: 22574633
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Personal privacy in the health care system: employer-sponsored insurance, managed care, and integrated delivery systems.
    Gostin LO
    Kennedy Inst Ethics J; 1997 Dec; 7(4):361-76. PubMed ID: 11655368
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Investigating the Extent to Which Patients Should Control Access to Patient Records for Research: A Deliberative Process Using Citizens' Juries.
    Tully MP; Bozentko K; Clement S; Hunn A; Hassan L; Norris R; Oswald M; Peek N
    J Med Internet Res; 2018 Mar; 20(3):e112. PubMed ID: 29592847
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Design of comprehensive Alzheimer's disease centers to address unmet national needs.
    Trojanowski JQ; Arnold SE; Karlawish JH; Brunden K; Cary M; Davatzikos C; Detre J; Gaulton G; Grossman M; Hurtig H; Jedrziewski K; McCluskey L; Naylor M; Polsky D; Schellenberg GD; Siderowf A; Shaw LM; Van Deerlin V; Wang LS; Werner R; Xie SX; Lee VM
    Alzheimers Dement; 2010 Mar; 6(2):150-5. PubMed ID: 20298979
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Patient-Centered Approach to Informed Consent: Results from a Survey and Randomized Trial.
    Krishnamurti T; Argo N
    Med Decis Making; 2016 Aug; 36(6):726-40. PubMed ID: 26964877
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fair Shares and Sharing Fairly: A Survey of Public Views on Open Science, Informed Consent and Participatory Research in Biobanking.
    Joly Y; Dalpé G; So D; Birko S
    PLoS One; 2015; 10(7):e0129893. PubMed ID: 26154134
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The treatment of Alzheimer's disease using Chinese medicinal plants: from disease models to potential clinical applications.
    Su Y; Wang Q; Wang C; Chan K; Sun Y; Kuang H
    J Ethnopharmacol; 2014 Mar; 152(3):403-23. PubMed ID: 24412377
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Data protection and data access (I): federal data protection law and the social welfare code with reference to carrying out occupational medicine epidemiologic studies in Germany].
    Weigelt E; Scherb H
    Gesundheitswesen; 1992 Nov; 54(11):666-72. PubMed ID: 1286250
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combination Therapy for Alzheimer's Disease: Perspectives of the EU/US CTAD Task Force.
    Gauthier S; Alam J; Fillit H; Iwatsubo T; Liu-Seifert H; Sabbagh M; Salloway S; Sampaio C; Sims JR; Sperling B; Sperling R; Welsh-Bohmer KA; Touchon J; Vellas B; Aisen P
    J Prev Alzheimers Dis; 2019; 6(3):164-168. PubMed ID: 31062826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.